【结 构 式】 |
【药物名称】Mifepristone, C-1073, CI-1073, RU-486, RU-38486, Mifeprex, Mifegyne 【化学名称】11beta-(4-Dimethylaminophenyl)-17beta-hydroxy-17alpha-(1-propynyl)estra-4,9-dien-3-one 【CA登记号】84371-65-3(Chiral);84371-65-3 【 分 子 式 】C29H35NO2 【 分 子 量 】429.6078 |
【开发单位】Aventis Pharma (Originator), National Institutes of Health (Not Determined), Kosan (Marketer), Danco (Licensee), Population Council (Licensee) 【药理作用】Abortifacients, Adrenocortical Dysfunction Therapy, Anxiolytics, Bipolar Disorder, Treatment of, Cushing's Syndrome, Agents for, ENDOCRINE DRUGS, Gynecological Disorders, Treatment of , Mood Disorders, Treatment of, Posttraumatic Stress Disorder (PTSD), Treatment of, PSYCHOPHARMACOLOGIC DRUGS, Glucocorticoid Receptor Antagonists, Progesterone Receptor Antagonists |
合成路线1
【1】 Neef G.Beier S,Elger W, et aL 1984. New steroids with antiprogestational and antiglucocorticoid activities Steroids, 44 (4): 349~372 |
【2】 Wiechert R.Ned G 1987. Synthesis of antiprogestational steroids. J Steroid Biochem, 27 (4-6): 851~858 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 66526 | 13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[5,10-epoxycyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-ol | C20H28O4 | 详情 | 详情 | |
(II) | 10863 | Bromo[4-(dimethylamino)phenyl]magnesium | 7353-91-5 | C8H10BrMgN | 详情 | 详情 |
(III) | 66527 | 11-(4-(dimethylamino)phenyl)-13-methyl-1,2,4,5,6,7,8,11,12,13,14,15,16,17-tetradecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane]-5,17-diol | C28H39NO4 | 详情 | 详情 | |
(IV) | 66528 | 11-(4-(dimethylamino)phenyl)-5-hydroxy-13-methyl-1,2,5,6,7,8,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17(4H)-one | C28H37NO4 | 详情 | 详情 | |
(V) | 66529 | C28H37NO4 | 详情 | 详情 | ||
(VI) | 43835 | 2-propynyl tetrahydro-2H-pyran-2-yl ether; 2-(2-propynyloxy)tetrahydro-2H-pyran | 6089-04-9 | C8H12O2 | 详情 | 详情 |
(VII) | 66530 | 11-(4-(dimethylamino)phenyl)-13-methyl-17-(3-((tetrahydro-2H-pyran-2-yl)oxy)prop-1-yn-1-yl)-1,2,4,5,6,7,8,11,12,13,14,15,16,17-tetradecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane]-5,17-diol | C36H49NO6 | 详情 | 详情 |
合成路线2
【1】 Rao PN. 2000. A practical large-scale synthesis of 17 alpha-acetoxy-ll beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione (CDB-2914). Steroids, 65 (7): 395~400 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 40864 | C21H27NO3 | 详情 | 详情 | ||
(II) | 40866 | C24H34ClNO3Si | 详情 | 详情 | ||
(III) | 40867 | (13S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one | 14340-01-3 | C20H26O3 | 详情 | 详情 |
(IV) | 40868 | C24H34O5 | 详情 | 详情 | ||
(V) | 40869 | C24H34O6 | 详情 | 详情 | ||
(VI) | 10863 | Bromo[4-(dimethylamino)phenyl]magnesium | 7353-91-5 | C8H10BrMgN | 详情 | 详情 |
(VII) | 40870 | C32H45NO6 | 详情 | 详情 |
合成路线3
【1】 Kim HK.1997. 21-Substituted progesterone derivatwes as new antiprogestational agents. W0 1997041145(本专利为US Department of Health & Human Servicres所有) |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 40864 | C21H27NO3 | 详情 | 详情 | ||
(II) | 41669 | C24H34BrNO3Si | 详情 | 详情 | ||
(III) | 66531 | C20H25BrO3 | 详情 | 详情 | ||
(IV) | 66532 | C22H28O5 | 详情 | 详情 | ||
(V) | 66533 | C20H26O4 | 详情 | 详情 | ||
(VI) | 41673 | C24H34O6 | 详情 | 详情 | ||
(VII) | 41674 | C25H36O6 | 详情 | 详情 | ||
(VIII) | 41675 | C25H36O7 | 详情 | 详情 | ||
(IX) | 10863 | Bromo[4-(dimethylamino)phenyl]magnesium | 7353-91-5 | C8H10BrMgN | 详情 | 详情 |
(X) | 41676 | C33H47NO7 | 详情 | 详情 |
合成路线4
The reaction of 3,3-(ethylenedioxy)estra-5(10),9(11)-diene-17(beta)-one (I) with propynylmagnesium bromine (II) in THF gives 3,3-(ethylenedioxy)-17(beta)-(propyn-1-yl)estra-5(10),9(11)-diene-17(beta)-ol (III), which is epoxidized with H2O2 in hexafluoroacetone-methylene chloride yielding 3,3-(ethylenedioxy)-17(beta)-(propyn-1-yl)-5(alpha),10(alpha)-epoxyestra-9(11)-en-17(beta)-ol (IV). The reaction of (IV) with 4-dimethylaminophenylmagnesium bromide (V) in THF affords 11(beta)-(4-dimethylaminophenyl)-3,3-(ethylenedioxy)-17(beta)-(propyn-1-yl)estra-9-en-17(beta)-ol (VI), which is finally deprotected by a treatment with HCl in metnanol.
【1】 Teutsch, J.G.; Costerousse, G.; Philibert, D.; Deraedt, R. (Aventis Pharma SA); Steroid. derivs. 11beta-substd.. FR 2497807; JP 1989279897; US 4447424; US 4978657; US 5043332 . |
【2】 Kottegoda, S.R.; Castaner, J.; Serradell, M.N.; Adaikan, P.G.; RU-486. Drugs Fut 1984, 9, 10, 755. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 30502 | 3,3-Ethylenedioxyestra-5(10),9(11)-dien-17-one | 5571-36-8 | C20H26O3 | 详情 | 详情 |
(II) | 30503 | bromo(1-propynyl)magnesium | C3H3BrMg | 详情 | 详情 | |
(III) | 30504 | 3,3-(Ethylenedioxy)-17alpha-(1-propynyl)estra-5(10),9(11)-dien-17-beta-ol | C23H30O3 | 详情 | 详情 | |
(IV) | 30505 | 5alpha,10alpha-Epoxy-3,3-(ethylenedioxy)-17alpha-(1-propynyl)estra-9(11)-en-17-beta-ol | C23H30O4 | 详情 | 详情 | |
(V) | 10863 | Bromo[4-(dimethylamino)phenyl]magnesium | 7353-91-5 | C8H10BrMgN | 详情 | 详情 |
(VI) | 30506 | 11beta-[4-(Dimethylamino)phenyl]-3,3-(ethylenedioxy)-17alpha-(1-propynyl)estra-4,9-diien-17-beta-ol | C31H39NO3 | 详情 | 详情 |